How breast cancer cells acquire drug resistance
Duke Cancer Institute researchers on a seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib have found a previously unknown molecular network that regulates cell death.
The discovery provides new avenues to overcome drug resistance, according to the researchers.